Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of COVID-19”

421 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 421 results

Not applicableStudy completedNCT05315323
What this trial is testing

Clinical Use of EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in Gulf Cooperation Council Countries

Who this might be right for
COVID-19
AstraZeneca 550
Not applicableStudy completedNCT04900961
What this trial is testing

CISCO-21 Prevent and Treat Long COVID-19.

Who this might be right for
Covid19
NHS Greater Glasgow and Clyde 233
Not applicableUnknownNCT04471766
What this trial is testing

Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention

Who this might be right for
COVID-19Respiratory Illness
Bandim Health Project 40,000
Not applicableStudy completedNCT04681001
What this trial is testing

Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers

Who this might be right for
Respiratory Viral InfectionCommon ColdSevere Acute Respiratory Syndrome (SARS) Pneumonia+2 more
Marinomed Biotech AG 300
Testing effectiveness (Phase 2)Study completedNCT04354870
What this trial is testing

COVID-19 PrEP HCW HCQ Study

Who this might be right for
COVID-19
NYU Langone Health 130
Large-scale testing (Phase 3)Study completedNCT04625972
What this trial is testing

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults

Who this might be right for
COVID-19
AstraZeneca 1,131
Not applicableStudy completedNCT05687877
What this trial is testing

Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)

Who this might be right for
SARS-CoV-2 Infection
AstraZeneca 366
Post-approval studies (Phase 4)Study completedNCT05165966
What this trial is testing

Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 340
Early research (Phase 1)WithdrawnNCT04887350
What this trial is testing

SSIPP vs. PST vs. WLC

Who this might be right for
Major Depressive DisorderLate Life Depression
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Testing effectiveness (Phase 2)Study completedNCT04342650
What this trial is testing

Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection

Who this might be right for
COVID-19SARS-CoV InfectionSevere Acute Respiratory Syndrome (SARS) Pneumonia+1 more
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado 152
Testing effectiveness (Phase 2)Study completedNCT04436276
What this trial is testing

Ad26.COV2.S in Adults (COVID-19)

Who this might be right for
Covid-19 Prevention
Janssen Vaccines & Prevention B.V. 1,085
Large-scale testing (Phase 3)Ended earlyNCT04318444
What this trial is testing

Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)

Who this might be right for
COVID-19Corona Virus Infection
Columbia University 10
Large-scale testing (Phase 3)Ended earlyNCT04472728
What this trial is testing

Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients

Who this might be right for
Covid-19SARS-CoV2
Biophytis 238
Large-scale testing (Phase 3)Study completedNCT04904471
What this trial is testing

A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)

Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 39,663
Not applicableStudy completedNCT05439044
What this trial is testing

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)

Who this might be right for
Immunocompromised Patients
Assistance Publique - Hôpitaux de Paris 4,235
Testing effectiveness (Phase 2)Study completedNCT04446377
What this trial is testing

LAM-002A for the Prevention of Progression of COVID-19

Who this might be right for
COVID-19 Disease
OrphAI Therapeutics 142
Very early researchUnknownNCT05679466
What this trial is testing

An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older

Who this might be right for
Prevention of COVID-19 Caused by SARS-CoV-2
Yu Qin 3,300
Not applicableStudy completedNCT05197673
What this trial is testing

Identifying Risks of COVID-19 Outbreaks in Work Settings and the Implications for Control Measures

Who this might be right for
Intention to Get SARS-CoV-2 VaccinationIntention to Get SARS-CoV-2 Antibody Test
Chinese University of Hong Kong 310
Large-scale testing (Phase 3)Study completedNCT05069649
What this trial is testing

Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2

Who this might be right for
Immunization Against COVID-19
Materia Medica Holding 1,057
Testing effectiveness (Phase 2)Study completedNCT06234956
What this trial is testing

Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.

Who this might be right for
SARS CoV 2 Infection
Hipra Scientific, S.L.U 242
Load More Results